SCHEMBL4880157

SCHEMBL4880157

CC1CCC(C(C)C)C(c2c[nH]c3ccccc23)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 5/20 0.52
HTR2A P28223 3/20 0.52
HTR2B P41595 3/20 0.52
SLC6A4 P31645 1/20 0.48
ADRB2 P07550 1/20 0.44
KDM4E B2RXH2 2/20 0.43
ATM Q13315 1/20 0.43
ALDH1A1 P00352 2/20 0.40
BRD4 O60885 1/20 0.40
POLB P06746 1/20 0.40
CREBBP Q92793 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
KCNA5 P22460 1/20 0.40
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
IDO1 P14902 3/20 0.38
AR P10275 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27765410 0.80 HTR2C (0.51) HTR2CHTR2AHTR2BSLC6A4ADRB2
SCHEMBL10700915 0.79 KCNA5 (0.50) ALDH1A1KCNA5LMNA
SCHEMBL7540738 0.76 KDM1A (0.49) SLC6A4ALDH1A1KCNA5DRD2LMNA
SCHEMBL27765409 0.75 HTR2C (0.51) HTR2CHTR2AHTR2BSLC6A4ADRB2
SCHEMBL10715246 0.75 TRPM8 (0.44) ALDH1A1KCNA5LMNA
SCHEMBL8498802 0.74 KCNA5 (0.46) HTR2CHTR2AHTR2BALDH1A1KCNA5
SCHEMBL5824341 0.73 OPRM1 (0.47) HTR2CHTR2AHTR2BALDH1A1KCNA5
SCHEMBL4631746 0.73 KCNA5 (0.41) ALDH1A1KCNA5LMNA
SCHEMBL8336802 0.73 KCNA5 (0.44) ALDH1A1KCNA5LMNA
SCHEMBL11858717 0.72 KCNA5 (0.39) ALDH1A1KCNA5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626174-A2 Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-11-30 EP claimed
US-8658231-B2 Coffee flavour modification process KRAFT FOODS R&D, INC. (US) 2014-02-25 US disclosed
US-20080299283-A1 COFFEE FLAVOUR MODIFICATION PROCESS INTERCONTINENTAL GREAT BRANDS LLC 2008-12-04 US disclosed
EP-1872665-A1 Coffee flavour modification process Kraft Foods R & D, Inc. Zweigniederlassung München (DE) 2008-01-02 EP disclosed
US-6147051-A ANTIISCHEMIC AGENT TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2000-11-14 US disclosed
EP-0626174-A2 Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-11-30 EP disclosed